Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.40 |
| ▸ | APP | P05067 | 3/20 | 0.38 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.38 |
| ▸ | CDK1 | P06493 | 1/20 | 0.38 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.38 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.38 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.38 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12278040 | 0.93 | KMT2A (0.59) | KMT2ACYP19A1HPGDSLC2A1ALDH1A1 | |
| SCHEMBL12278820 | 0.90 | KMT2A (0.53) | KMT2ACYP19A1HPGDSLC2A1ALDH1A1 | |
| SCHEMBL12278770 | 0.86 | KMT2A (0.46) | KMT2ACYP19A1HPGDALDH1A1KDM4E | |
| SCHEMBL12278835 | 0.85 | KMT2A (0.41) | KMT2ACYP19A1HPGDALDH1A1KDM4E | |
| SCHEMBL12278066 | 0.84 | KMT2A (0.45) | KMT2ACYP19A1HPGDALDH1A1KDM4E | |
| SCHEMBL12278038 | 0.84 | KMT2A (0.53) | KMT2ACYP19A1HPGDSLC2A1ALDH1A1 | |
| SCHEMBL8305794 | 0.82 | KMT2A (0.72) | KMT2ACYP19A1HPGDSLC2A1ALDH1A1 | |
| SCHEMBL12278758 | 0.80 | KMT2A (0.46) | KMT2ACYP19A1HPGDALDH1A1SMN1; SMN2 | |
| SCHEMBL12278757 | 0.80 | KMT2A (0.46) | KMT2ACYP19A1HPGDALDH1A1KDM4E | |
| SCHEMBL13563012 | 0.80 | KMT2A (0.50) | KMT2ACYP19A1HPGDSLC2A1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8785915-B2 | Compound for organic thin film transistor and organic thin film transistor using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-07-22 | — | — | US | disclosed |
| US-8785915-B2 | Compound for organic thin film transistor and organic thin film transistor using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-07-22 | — | — | US | disclosed |
| US-20110210319-A1 | COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME | COMPOUND FOR ORGANIC THIN FLIM TRANSISTOR AND ORGANIC THAN FLIM TRANSITOR USING THE SAME (JP) | 2011-09-01 | — | — | US | disclosed |
| US-20110210319-A1 | COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME | COMPOUND FOR ORGANIC THIN FLIM TRANSISTOR AND ORGANIC THAN FLIM TRANSITOR USING THE SAME (JP) | 2011-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110210319-A1 | COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME | OR10J3, TCF4, CTCF | KMT2A 366/4885CYP19A1 321/4885HPGD 4640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.